NCT01682889View on ClinicalTrials.gov

The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2012

Conditions
Peripheral Arterial Occlusive Disease
Interventions
DIETARY_SUPPLEMENT

Arginine

L-arginine-hydrochlorid (0.35 g/kg body weight) intravenously for 24 hours

DIETARY_SUPPLEMENT

Placebo

NaCl 0.9% intravenously for 24h

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical Scientific Fund of the Mayor of Vienna

OTHER

NCT01682889 - The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation | Biotech Hunter | Biotech Hunter